← All stocks

NEOGEN CORP

NEOG Net buying
CIK 0000711377 #1852 in the set updated 18 Sep 2026
Bought (12 mo)
$7.49K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$7.49K
+$7.49K against sales at will

By person

20 insiders · 37 transactions

There is no salary here to measure against. NEOGEN CORP's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Nassif Mikheal
CEO
$7.49K (6)
+$7.49K
142,705
0.0654%
$1.69M
ADENT JOHN EDWARD
Former CEO
363,081
0.1665%
$4.29M
+103.3%
Jones Douglas Edward
Former COO
100,881
0.0463%
$1.19M
+100.0%
BOREL JAMES C
Director
94,570
0.0434%
$1.12M
Naemura David H.
Former CFO
90,388
0.0415%
$1.07M
Rocklin Amy M
Former Chief Legal Officer
82,182
0.0377%
$970.57K
Riggsbee Richard Bryan
CFO
51,502
0.0236%
$608.24K
BOEHM WILLIAM T
Director
47,913
0.0220%
$565.85K
+76.6%
Tobin James P
Director
43,347
0.0199%
$511.93K
+124.1%
Stacey Jennifer Evans
Chief Legal Officer
38,627
0.0177%
$456.18K
CAPELLO JEFFREY D
Director
30,725
0.0141%
$362.86K
Gupta Aashima
Director
27,790
0.0127%
$328.20K
Ranalli Tamara A.
Senior Vice President
25,751
0.0118%
$304.12K
RODRIGUEZ RAFAEL A
Director
20,821
0.0095%
$245.90K
Wainer Andrea F
Director
19,769
0.0091%
$233.47K
Bernard Thierry
Director
19,769
0.0091%
$233.47K
Pelossof Avi
Director
19,386
0.0089%
$228.95K
Woteki Catherine E
Director
19,117
0.0088%
$225.77K
Green Ronald D
Director
18,654
0.0086%
$220.30K
Moylan John Patrick
Chief Accounting Officer
17,337
0.0080%
$204.75K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,019,755
History held since 30 Sep 2016